Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in RAS wild-type metastatic colorectal cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hao Chen, Tao Jiang, Han Wang, JW Zheng, Bin Du, Xiaojiao Weng, Na Yao, Yingjiao Zhu, Qing Liu, Fangyu Lin, Xinli Wang, Xiaoyan Lin
Institution: Union Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162568232
Cites:
Cited by:
Related to: